Supergenics

SGBHD

MYL03033O007

Construction & Engineering

End-of-day quote BURSA MALAYSIA Other stock markets 23:00:00 10/03/2024 GMT			5-day change	1st Jan Change
0.5 ^MYR	-1.96%		-.--%	+117.39%

04-02	Supergenics Seeks More Time to Complete Private Share Placement	MT
02-29	Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Supergenics Berhad Reports Earnings Results for the Half Year Ended June 30, 2020

August 28, 2020 at 01:42 pm

Supergenics Berhad announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was MYR 1.624 million. Operating loss was MYR 615,000. Net loss was MYR 774,000. Basic loss per share was MYR 0.0084.

Latest news about Supergenics

Supergenics Seeks More Time to Complete Private Share Placement	04-02	MT
Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2023	02-29	CI
41,850,000 Ordinary Shares of Supergenics Berhad are subject to a Lock-Up Agreement Ending on 6-JAN-2024.	01-05	CI
Supergenics Berhad Appoints LAU MENG HONG as Executive Director	12-08	CI
Supergenics Berhad Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23	CI
Supergenics Berhad announced that it expects to receive MYR 6 million in funding	03/08/23	CI
Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2022	28/02/23	CI
Supergenics Berhad Announces Change of Registered Address	30/11/22	CI
Supergenics Turns to Profit in H1	29/08/22	MT
Supergenics Berhad Reports Earnings Results for the Half Year Ended June 30, 2022	26/08/22	CI
Supergenics Berhad Announces Appointment of Wong Yuet Chyn as Company Secretary	02/06/22	CI
Supergenics Berhad Announces Resignation of Ramnath A/L R.Sundaram as Company Secretary	02/06/22	CI
Supergenics Berhad Announces Change of Registered Address	02/06/22	CI
Supergenics Berhad Announces Resignation of Rafidah Binti Ibrahim as Company Secretary	02/06/22	CI
Supergenics Berhad Appoints Chua Kien Hui as Executive Director	10/05/22	CI
Supergenics Berhad Announces Resignation of Mr. Tan Pin Yuan as Executive Director	22/04/22	CI
Supergenics Berhad Reports Earnings Results for the Full Year Ended December 31, 2021	28/02/22	CI
Supergenics Berhad Appoints Chan Kiat Yang as Executive Director	28/01/22	CI
Supergenics Berhad Reports Condensed Consolidated Earnings Results for the Half Year Ended June 30, 2021	30/08/21	CI
Supergenics Berhad Announces Revenue Results for the Full Year Ended December 31, 2020	30/04/21	CI
Supergenics Berhad Announces Earnings Results for the Second Half Year and Full Year Ended December 31, 2020	26/02/21	CI
26,150,000 Ordinary Shares of Supergenics Berhad are subject to a Lock-Up Agreement Ending on 6-JAN-2021.	05/01/21	CI
Supergenics Berhad Reports Earnings Results for the Half Year Ended June 30, 2020	28/08/20	CI
Supergenics Berhad Announces Final Dividend for the Financial Year Ended 31 December 2019, Payable on August 28, 2020	30/07/20	CI

Chart Supergenics

Duration

Period

More charts

Company Profile

Supergenics Berhad is a Malaysia-based management and investment holding company. The Company operates through three segments: Integrated turnkey solutions, Biomedical and Investment holding. The Company is engaged in the provision of integrated turnkey solutions for the related development of cleanroom and the provision of related maintenance services. The Biomedical segment is engaged in the provision of administrative health care services and operating of medical laboratories and developing of medical treatment and wellness products. The Company provides facility planning, designing, constructing, installing, validating, monitoring and maintaining cleanrooms in order to create an indoor environment suitable for activities which require a certain air quality. Its subsidiaries include Supergenics Solution Sdn Bhd, Supergenics Life Science Sdn Bhd and Supergenics Therapeutic Sdn Bhd.

Sector

Construction & Engineering

Calendar

27/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Construction & Engineering

	1st Jan change	Capi.
SUPERGENICS	+117.39%	12.29M
VINCI	+0.66%	70.81B
LARSEN & TOUBRO LIMITED	+3.98%	60.4B
QUANTA SERVICES, INC.	+27.87%	40.39B
CHINA STATE CONSTRUCTION ENGINEERING CORPORATION LIMITED	+17.05%	32.36B
FERROVIAL SE	+9.81%	28.8B
CHINA RAILWAY GROUP LIMITED	+15.85%	20.92B
WSP GLOBAL INC.	+10.37%	18.74B
EMCOR GROUP, INC.	+80.41%	18.27B
CHINA COMMUNICATIONS CONSTRUCTION COMPANY LIMITED	+35.06%	17.07B